Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mattias Rudebeck

8PUBLICATIONS
21CO-AUTHORS
Nutrigenomics and personalised nutritionMajor global burdens of diseaseBiomaterialsMedical biochemistry - amino acids and metabolitesNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jul 27, 2025
Long-Term Efficacy and Tolerability of Pegzilarginase in Arginase 1 Deficiency: Results of Two International Multicentre Open-Label Extension Studies.

Markey McNutt, Frank Rutsch, Rossana Sanchez Russo

|Sep 04, 2024
Societal costs and quality of life associated with arginase 1 deficiency in a European setting - a multinational, cross-sectional survey.

Sara Olofsson, Sofia Löfvendahl, Julia Widén

|Jul 14, 2023
Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients.

Federica Genovese, Peder Frederiksen, Anne-Christine Bay-Jensen

|Oct 27, 2022
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria.

Lakshminarayan R Ranganath, Andrew T Hughes, Andrew S Davison

|Aug 25, 2022
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.

Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes

|Jan 14, 2022
Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria.

Birgitta Olsson, Lakshminarayan Ranganath, Jean-Baptiste Arnoux

Pageof 2

Frequent Collaborators

2 joint publications

Andrew S Davison

2 joint publications

Brendan P Norman

2 joint publications

Anna M Milan

1 joint publications

Federica Genovese

1 joint publications

Anne-Christine Bay-Jensen

1 joint publications

Sara Olofsson

1 joint publications

Sofia Löfvendahl

1 joint publications

Julia Widén

1 joint publications

Peter Lindgren

1 joint publications

Karolina M Stepien

Frequent Collaborators

2 joint publications

Andrew S Davison

2 joint publications

Brendan P Norman

2 joint publications

Anna M Milan

1 joint publications

Federica Genovese

Top Related Videos

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on : Dec 20, 2017

8.2K
Preparation of Naringenin Solution for <em>In Vivo</em> Application
08:18

Preparation of Naringenin Solution for <em>In Vivo</em> Application

Published on : Aug 10, 2021

3.4K
See more related videos

Top Related Videos

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on : Dec 20, 2017

8.2K
Preparation of Naringenin Solution for <em>In Vivo</em> Application
08:18

Preparation of Naringenin Solution for <em>In Vivo</em> Application

Published on : Aug 10, 2021

3.4K
See more related videos